Neurological Complications of Wegener's Granulomatosis
Arch Neurol l8:45, 1963, Drachman,D., 1963
Neuro CPC of MGH
Multiple Sclerosis, Cerebral Infarcts, & Colitis, NEJM 268:607-615., , 1963
Neuro CPC of MGH
Cerebral Embolism & Infarction, NEJM 267:1084-109162., , 1962
Candida Endocarditis-Clinical & Pathologic Studies
Am J Med 32:251-285, 1962, Andriole,V.T.,et al, 1962
Pathology of Cerebral Arterial Occlusion
Fields, Wm. , Pathogenesis & Treatment of CVD., Adams,R.,et al, 1961
Clinical Syndromes in Cerebral Arterial Occlusion
(Ed) , Fields, Wm. Pathogenesis & Treatment of CVD, Charles C. Thomas, Publisher, Fisher,C.M., 1961
Occlusive Cerebrovascular Disease
Am J Med 30:577, Meyer,J.S., 1961
Cerebral Embolism Caused by Nonbacterial Thrombotic Endocarditis
Neurol 10:391, Barron,K.D.,et al, 1960
Cerebral Hemorrhage In Leukemia
Arch Neurol 2:439-451, Groch,S.N.,et al, 1960
Neuro CPC of MGH
Acute Bacterial Endocarditis with Cerebral Emboli, NEJM 260:1085-10881959., , 1959
Increased Spinal Fluid Protein in Hyperparathyroidism & Other Hypercalcemic States
Arch Int Med 104:29, Edwards,G.,et al, 1959
Neuro CPC of MGH
Cerebral Infarcts Due to Paradoxical Emboli, NEJM 258:338-3451958., , 1958
Bilateral Loss of Vision from Cerebral Infarction
Brain 80:28, Symonds,C.,et al, 1957
The Significance of Nonbacterial Thrombotic Endocarditis:An Autopsy & Clinical Study of 78 Cases
Ann Int Med 46:255, MacDonald,R.A.,et al, 1957
Cerebrovascular Accidents in Patients with Congenital Heart Disease
Arch Neurol & Psychiat 77:483957., Tyler,H.R.,et al, 1957
Neurologic Signs & Symptoms as Early Manifestations of SLE
Neurol 5:84, Siekert,R.,et al, 1955
Occlusion of the Basilar Artery-A Clinical & Pathological Study
Brain 69:73, Kubik,C.,et al, 1946
Cerebellar Ataxia in Children
Handout & References., Gilbert,J.J., 1850
Brachial artery embolus mimicking acute stroke
, Holmstedt, C. & Chimowitz, M.,
10 Things You Should Know About Cerebral Amyloid Angiopathy
Stroke 57:e69-e742026, Charidimou,A.,
Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After IschemicStroke, The OPTION Randomized Clinical Trial
JAMA doi:10.1001/JAMA.2026.0210, Ma,G.,et al, 2026
A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion
NEJM 394:442-450, Ryan,S.J.,et al, 2026
Mucormycosis
NEJM 394:684-698, Kontoyiannia,D.P. & Walsh, T.J., 2026
Clinicopathologic Conference, Lyme Neuroborreliosis and Coinfection with Babesia Microti
NEJM 394:383-391, Case 3-2026, 2026
Medical Management and Revascularization for Asymptomatic Carotid Stenosis
NEJM 394:219-231 296, Hrott,T.G.,et al, 2026
Clinicopathologic Conference, Disseminated Infection with Hypervirulent Klebsiella Pneumoniae
NEJM 394:282-294, Case 202026, 2026
Reversible Leukoencephalopathy and Parkinsonism Due to CNS Involvement in Cryoglobulinemia
Neurol 106:e214622, German,A.,et al, 2026
Stroke Mechanism and Severity after Left Atrial Appendage Occlusion, Insights from the LAAOS III Randomized Clinical Trial
JAMA Neurol 83:76-82, Katsanos,A.H.,et al, 2026
Intravenous Thrombolysis Use in the Late Time Window Before Interhospital Transfer for Thrombectomy
JAMA Neurol 83:60-67, Seners,P.,et al, 2026
CT Perfusion Abnormality in Hypoglycemic Focal Neurological Deficits
Stroke 57:e6-e7, Mikito,S.,et al, 2026
Congenital Zika Syndrome
NEJM 394:e2, Bacin,F. & Montenegro,M.A., 2026
Diffuse Cerebellar Involvement with Obstructive Hydrocephalus in Powassan Virus Encephalitis
Neurol 107:e218290, Xu,Z.,et al, 2026
Alzheimers Disease
Lancet 407:2241-2262, Serrano-Pozo, A.,et al, 2026
Antidotes for Anticoagulation Reversal
NEJM 394:2235-2254, Rocca,B., and Cate,H.T., 2026
Application of the 2024 McDonald Criteria in Individuals with Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter Study
Neurol 107:e218138, e218210, Scharf,A.,et al, 2026
Current Management of Cerebral Venous Thrombosis
Stroke 57:2228-2236, Field,T.S. & Fragata,I., 2026
Motor Aprosodia:When Stroke Speaks in Monotone
Ann Neurol 100:343-344, Jumah,A.,et al, 2026
Clinicopathologic Conference, Neuroretinitis Due to Bartonella Henselae Infection
NEJM 395:389-398, Case 21-2026, 2026
Efficacy and Safety of Ecopipam for Tourette Syndrome A Phase 3 Randomized Clinical Trial
JAMA Neurol 83:645-653, Gilbert,D.L.,et al, 2026
Creutzfeldt-Jakob-Like Presentation in Anti-AMPAR Encephalitis
Ann Neurol 99:1466-1467, Durbano,K.et al, 2026
Safety and Outcomes of Dibigatran Reversal with Idarucizumab Before IV Thrombolysis in Patients with Acute Ischemic Stroke
Neurol 106:e218012, Saflund,M.,et al, 2026
Late-Onset Seizures, Etiology and Demographics in US Tertiary Care Epilepsy Centers
Neurol 106:e214948, Blank,L.J.,et al, 2026
A 41-Year-Old Man Presenting with Right Foot Tingling
Neurol 106:214781, Lu,V.,et al, 2026
Case Fatality of Subarachnoid hemorrhge by Aneurysm Location
Neurol 106:e214918, Asikinen,.,et al, 2026
Diagnostic Value of the Kappa Free light Chain Index to Distinguish MOGAD, NMOSD, and MS
Neurol 106:e214946, Tournier,A.,et al, 2026
Using Susceptibility-Based Imaging in highly ctive Late-Onset Multiple Sclerosis
Neurol 106:e214794, Sosa,S.M.,et al, 2026
Asundexian for Secondary Stroke Prevention
NEJM 394:1467-1479, 1540, Sharm,M.,et al, 2026
Myelitis-Predominant Agressive Phenotype:Unveiling Unique Paterns of Late-Onset Neuromyelitis Optica Spectrum Disorders
Ann Neurol 99:1139-1151, Pu,Y-L.,et al, 2026
Endovascular Therapy for Medium-Vessel Occlusion Stroke - Narrowing the Target Population
NEJM 394:1955-1957,1894, Ospel,J.M. & Hill, M.D., 2026
A 28-Year-Old Man with Seizures and Thalamic Lesions
Neurol 106:e218065, Santos-Rojo,A.B.,et al, 2026